Dandex

PHARMACEUTICAL ECONSULTING A/S

CVR 30815378Public limited company (A/S)Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)GlostrupFounded 3 Sep 2007

Employees

9

CVR registry, Jul 2026

0 (0%) over 12 months

Gross profit

6,1M

DKK, annual report 2025

+10,4% on 2024

Result

-1,1M

DKK, annual report 2025

Equity

5,2M

DKK, annual report 2025

Who Is Behind It

Owner

RUGAARD HOLDING ApSCVR 30815351, 100% of capital and votes, since 3 Sep 2007

Ultimate controller
Steen Otto Rugaardthrough RUGAARD HOLDING ApS, a Dandex estimate, owner-managed
Director

Steen Otto Rugaardsince 14 Jun 2016

Ownership

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

Control Chain

  1. Ultimate controller

    Steen Otto Rugaard

    Holds 100% of capital and votes in RUGAARD HOLDING ApS, since 3 Sep 2007

    Capital100%
    Votes100%
  2. Holding company

    RUGAARD HOLDING ApS

    CVR 30815351Private limited company (ApS)

    Holds 100% of capital and votes in PHARMACEUTICAL ECONSULTING A/S, since 3 Sep 2007

    Capital100%
    Votes100%
  3. This company

    PHARMACEUTICAL ECONSULTING A/S

    CVR 30815378

Each holds the one below it. Control follows votes: an owner with 50% or more controls. Each bar shows the registered band, solid to its lower bound and faint across the range CVR records, with a mark at 50%. Dandex estimate, computed 20 Oct 2026.

People

Current (3)

Founders (1)

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Former (1)

Network

Roles Over Time

  • Steen Otto Rugaard: Executive board, 14 Jun 2016 to today; Board of directors, 14 Jun 2016 to today; Executive board, 3 Sep 2007 to 6 Apr 2016; Board of directors, 3 Sep 2007 to 6 Apr 2016.
  • Hanne Laurberg Olesen: Board of directors, 14 Jun 2016 to today; Board of directors, 3 Sep 2007 to 6 Apr 2016.
  • Pernille Laurberg Rugaard: Board of directors, 14 Jun 2016 to today; Board of directors, 1 Oct 2007 to 6 Apr 2016.

3 Sep 2007 to 20 Oct 2026.

Former (1)

1 Oct 2007 to 20 Oct 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Financials

Annual report figures by year, DKK thousands
Metric20212022202320242025
Gross profit8.2766.7795.5795.5386.114
Operating profit+3.050+770-395-941-1.268
Result for the year+2.420+780-384-644-1.067
Equity6.4677.2476.8636.2205.153
Total assets19.6588.0927.9918.80610.595
Employees (average)58880

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.

Annual Reports

  • Annual report 2025

    1 Oct 2024 to 30 Sep 2025, published 17 Apr 2026

  • Annual report 2024

    1 Oct 2023 to 30 Sep 2024, published 11 Apr 2025

  • Annual report 2023

    1 Oct 2022 to 30 Sep 2023, published 25 Apr 2024

  • Annual report 2022

    1 Oct 2021 to 30 Sep 2022, published 6 Apr 2023

  • Annual report 2021

    1 Oct 2020 to 30 Sep 2021, published 16 Mar 2022

Registration

Address
Naverland 2
2600 Glostrup
Albertslund Municipality
CVR record last changed
17 Apr 2026
Data read
20 Oct 2026

Production Units

1 registered in CVR.

  • PHARMACEUTICAL ECONSULTING A/S

    P-number 1013575963Naverland 2, 2600 Glostrup

Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ask About PHARMACEUTICAL ECONSULTING A/S With AI

Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.